Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook-square
  • x
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > News & Updates > Regulatory Updates > General

General

Directive for Mandatory Data Validation on eApp Software for Integration with Track and Trace System.

Ijaz Mustafa General August 6, 2026August 6, 2026
DirectiveDownload

Training Session on the Online Module of Ethical Marketing Expenditure Reporting System.

Ijaz Mustafa General July 29, 2026July 29, 2026
Ethical Marketing TrainingDownload

Guidelines on GS1 Datamatrix Barcode and Serialization of Pharmaceutical Products

Ijaz Mustafa General July 28, 2026July 29, 2026
Guidelines on T&TDownload

Mandatory Requirement of Auditor’s Report Bearing UDIN for Issuance of Nothing Due Certificate (NDC) in Respect of Central Research Fund

Ijaz Mustafa General July 24, 2026July 24, 2026
Mandatory RequirementDownload

Intimation Regarding Capacity Building and Technical Awareness Session on 2-D barcode and Serialization Implementation

Ijaz Mustafa General July 24, 2026July 24, 2026
Pharma bureau letterDownload

Consultative Meeting on Refurbished Medical Device Regulations 2026

Ijaz Mustafa General, Medical Devices July 23, 2026July 23, 2026
Consultative meeting on Refurbished Medical device regulations 23-Jul-2026 11-29-19Download

Draft  Medical Devices(Refurbishment)  Regulations, 2026 for comments of the stakeholders.

Ijaz Mustafa General, Notifications July 20, 2026July 20, 2026
Draft Medical Devices (Refurbishment) Regulations 2026 (20.07.2026)Download

Mandatory Transition from Conventional to Safety Engineered Reuse-Prevention(RUP) Syringes and Restrictions on Manufacture/Import/Sale of Conventional Syringes

Ijaz Mustafa General July 10, 2026July 10, 2026
20260710110223102Download
20260710110305645Download

Mandatory Transition from Conventional to Safety Engineered Reuse-Prevention(RUP) Syringes and Restrictions on Manufacture/Import/Sale of Conventional Syringes

Ijaz Mustafa General July 2, 2026July 2, 2026
Decision of MDB on Syringes-Letter to Mfr & ImpDownload
Decision of MDB on Syringes-Letter to StakeholdersDownload

Possible Interruption in E-Services due to Internet disruption

Yasir Mahmood General June 29, 2026June 29, 2026

Due to unavoidable issues in internet services, you may face trouble or unavailability of online systems until the issue is resolved.

  • ← Previous
  • Next →
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General

Quick Navigation

     
  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem
  • <
  • <